View More View Less
  • 1 Friedrich-Schiller-University of Jena Department of Internal Medicine/Cardiology Jena Germany
  • | 2 Friedrich-Schiller-University of Jena Institute of Medical Microbiology Jena Germany
  • | 3 SIRS-Lab GmbH Jena Germany
  • | 4 Moldiax GmbH Jena Germany
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Human cytomegalovirus (HCMV) infection may be involved in the pathogenesis of atherosclerosis by modulating functions of smooth muscle cells (SMC). In this study, we performed an oligonucleotide microarray screening of 780 inflammation-associated genes in HCMV-infected aortic SMC (AoSMC). The expression of 31 genes was stimulated and 24 genes were down-regulated following infection with HCMV strain DC-134. Following infection with HCMV strain AD-169 infection, we found 24 genes to be stimulated and 32 genes to be down-regulated. Among these were primarily genes encoding for CC and CXC chemokines, adhesion molecules, and tumor necrosis factor (TNF) receptor superfamily members, apoptosis-related factors, signal transduction molecules and transcription regulators. The up-regulated genes included matrix metalloproteinase (MMP)-1 and MMP-3 in HCMV infected cells. Using RT-PCR and enzyme immunoassay we found stimulated expression of MMP-1 (3.2-fold expression) and MMP-3 (334-fold expression) in HCMV strain DC-134-infected AoSMC at 72 h following infection.The findings of our study suggest that HCMV infection of AoSMC cause an activation of atherosclerosis-relevant factors in SMC. The increased expression of MMPs which have been shown to be involved in atherosclerotic plaque rupture and myocardial infarction is in agreement with the hypothesis that this pathogen might contribute to plaque inflammation in atherosclerotic disease.

  • Ross, R.: Atherosclerosis — an inflammatory disease. N. Engl. J. Med. 340, 115–126 (1999).

    Ross R. , 'Atherosclerosis — an inflammatory disease ' (1999 ) 340 N. Engl. J. Med. : 115 -126.

    • Search Google Scholar
  • Hansson, G. K.: Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685–1695 (2005).

    Hansson G. K. , 'Inflammation, atherosclerosis, and coronary artery disease ' (2005 ) 352 N. Engl. J. Med. : 1685 -1695.

    • Search Google Scholar
  • Melnick, J. L., Petrie, B. L., Dreesman, G. R., Burek, J., McCollum, C. H., DeBakey, M. E.: Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 2, 644–647 (1983).

    DeBakey M. E. , 'Cytomegalovirus antigen within human arterial smooth muscle cells ' (1983 ) 2 Lancet : 644 -647.

    • Search Google Scholar
  • Merigan, T. C., Renlund, D. G., Keay, S., Bristow, M. R., Starnes, V., O’Connell, J. B., Resta, S., Dunn, D., Gamberg, P., Ratkovec, R. M. et al.: A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N. Engl. J. Med. 326, 1182–1186 (1992).

    Ratkovec R. M. , 'A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation ' (1992 ) 326 N. Engl. J. Med. : 1182 -1186.

    • Search Google Scholar
  • Speir, E., Modali, R., Huang, E. S., Leon, M. B., Shawl, F., Finkel, T., Epstein, S. E.: Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265, 391–394 (1994).

    Epstein S. E. , 'Potential role of human cytomegalovirus and p53 interaction in coronary restenosis ' (1994 ) 265 Science : 391 -394.

    • Search Google Scholar
  • Roberts, E. T., Haan, M. N., Dowd, J. B., Aiello, A. E.: Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am. J. Epidemiol. 172, 363–371 (2010).

    Aiello A. E. , 'Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up ' (2010 ) 172 Am. J. Epidemiol. : 363 -371.

    • Search Google Scholar
  • Vliegen, I., Duijvestijn, A., Grauls, G., Herngreen, S., Bruggeman, C., Stassen, F.: Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation. Microbes Infect. 6, 17–24 (2004).

    Stassen F. , 'Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation ' (2004 ) 6 Microbes Infect. : 17 -24.

    • Search Google Scholar
  • Soule, J. L., Streblow, D. N., Andoh, T. F., Kreklywich, C. N., Orloff, S. L.: Cytomegalovirus accelerates chronic allograft nephropathy in a rat renal transplant model with associated provocative chemokine profiles. Transplant. Proc. 38, 3214–3220 (2006).

    Orloff S. L. , 'Cytomegalovirus accelerates chronic allograft nephropathy in a rat renal transplant model with associated provocative chemokine profiles ' (2006 ) 38 Transplant. Proc. : 3214 -3220.

    • Search Google Scholar
  • Streblow, D. N., Kreklywich, C., Yin, Q., De La Melena, V. T., Corless, C. L., Smith, P. A., Brakebill, C., Cook, J. W., Vink, C., Bruggeman, C. A., Nelson, J. A., Orloff, S. L.: Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J. Virol. 77, 2182–2194 (2003).

    Orloff S. L. , 'Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants ' (2003 ) 77 J. Virol. : 2182 -2194.

    • Search Google Scholar
  • Tikkanen, J., Kallio, E., Pulkkinen, V., Bruggeman, C., Koskinen, P., Lemstrom, K.: Cytomegalovirus infection-enhanced chronic rejection in the rat is prevented by antiviral prophylaxis. Transplant. Proc. 33, 1801 (2001).

    Lemstrom K. , 'Cytomegalovirus infection-enhanced chronic rejection in the rat is prevented by antiviral prophylaxis ' (2001 ) 33 Transplant. Proc. : 1801 -.

    • Search Google Scholar
  • Zeng, H., Waldman, W. J., Yin, D. P., Knight, D. A., Shen, J., Ma, L., Meister, G. T., Chong, A. S., Williams, J. W.: Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats. Transplantation 79, 17–22 (2005).

    Williams J. W. , 'Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats ' (2005 ) 79 Transplantation : 17 -22.

    • Search Google Scholar
  • Lemstrom, K., Koskinen, P., Krogerus, L., Daemen, M., Bruggeman, C., Hayry, P.: Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection. Circulation 92, 2594–2604 (1995).

    Hayry P. , 'Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection ' (1995 ) 92 Circulation : 2594 -2604.

    • Search Google Scholar
  • Lemstrom, K. B., Bruning, J. H., Bruggeman, C. A., Lautenschlager, I. T., Hayry, P. J.: Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J. Clin. Invest. 92, 549–558 (1993).

    Hayry P. J. , 'Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts ' (1993 ) 92 J. Clin. Invest. : 549 -558.

    • Search Google Scholar
  • Gerna, G., Baldanti, F., Revello, M. G.: Pathogenesis of human cytomegalovirus infection and cellular targets. Hum. Immunol. 65, 381–386 (2004).

    Revello M. G. , 'Pathogenesis of human cytomegalovirus infection and cellular targets ' (2004 ) 65 Hum. Immunol. : 381 -386.

    • Search Google Scholar
  • Reeves, M. B., Coleman, H., Chadderton, J., Goddard, M., Sissons, J. G., Sinclair, J. H.: Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo. J. Gen. Virol. 85, 3337–3341 (2004).

    Sinclair J. H. , 'Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo ' (2004 ) 85 J. Gen. Virol. : 3337 -3341.

    • Search Google Scholar
  • Evers, D. L., Wang, X., Huang, E. S.: Cellular stress and signal transduction responses to human cytomegalovirus infection. Microbes Infect. 6, 1084–1093 (2004).

    Huang E. S. , 'Cellular stress and signal transduction responses to human cytomegalovirus infection ' (2004 ) 6 Microbes Infect : 1084 -1093.

    • Search Google Scholar
  • Bouis, D., Kusumanto, Y., Meijer, C., Mulder, N. H., Hospers, G. A.: A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol. Res. 53, 89–103 (2006).

    Hospers G. A. , 'A review on pro- and anti-angiogenic factors as targets of clinical intervention ' (2006 ) 53 Pharmacol. Res. : 89 -103.

    • Search Google Scholar
  • Clinton, S. K., Libby, P.: Cytokines and growth factors in atherogenesis. Arch. Pathol. Lab. Med. 116, 1292–1300 (1992).

    Libby P. , 'Cytokines and growth factors in atherogenesis ' (1992 ) 116 Arch. Pathol. Lab. Med. : 1292 -1300.

    • Search Google Scholar
  • Baumert, J., Schmidt, K. H., Eitner, A., Straube, E., Rodel, J.: Host cell cytokines induced by Chlamydia pneumoniae decrease the expression of interstitial collagens and fibronectin in fibroblasts. Infect. Immun. 77, 867–876 (2009).

    Rodel J. , 'Host cell cytokines induced by Chlamydia pneumoniae decrease the expression of interstitial collagens and fibronectin in fibroblasts ' (2009 ) 77 Infect. Immun. : 867 -876.

    • Search Google Scholar
  • Huber, W., von Heydebreck, A., Sueltmann, H., Poustka, A., Vingron, M.: Parameter estimation for the calibration and variance stabilization of microarray data. Stat. Appl. Genet. Mol. Biol. 2, Article 3 (2003).

  • Rodel, J., Prochnau, D., Prager, K., Baumert, J., Schmidt, K. H., Straube, E.: Chlamydia pneumoniae decreases smooth muscle cell proliferation through induction of prostaglandin E2 synthesis. Infect. Immun. 72, 4900–4904 (2004).

    Straube E. , 'Chlamydia pneumoniae decreases smooth muscle cell proliferation through induction of prostaglandin E2 synthesis ' (2004 ) 72 Infect. Immun. : 4900 -4904.

    • Search Google Scholar
  • Gordon, D., Reidy, M. A., Benditt, E. P., Schwartz, S. M.: Cell proliferation in human coronary arteries. Proc. Natl Acad. Sci. U S A 87, 4600–4604 (1990).

    Schwartz S. M. , 'Cell proliferation in human coronary arteries ' (1990 ) 87 Proc. Natl Acad. Sci. U S A : 4600 -4604.

    • Search Google Scholar
  • Libby, P., Ridker, P. M., Maseri, A.: Inflammation and atherosclerosis. Circulation 105, 1135–1143 (2002).

    Maseri A. , 'Inflammation and atherosclerosis ' (2002 ) 105 Circulation : 1135 -1143.

  • Dumortier, J., Streblow, D. N., Moses, A. V., Jacobs, J. M., Kreklywich, C. N., Camp, D., Smith, R. D., Orloff, S. L., Nelson, J. A.: Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing. J. Virol. 82, 6524–6535 (2008).

    Nelson J. A. , 'Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing ' (2008 ) 82 J. Virol. : 6524 -6535.

    • Search Google Scholar
  • Renne, R., Barry, C., Dittmer, D., Compitello, N., Brown, P. O., Ganem, D.: Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus. J. Virol. 75, 458–468 (2001).

    Ganem D. , 'Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus ' (2001 ) 75 J. Virol. : 458 -468.

    • Search Google Scholar
  • Stoneman, V. E., Bennett, M. R.: Role of apoptosis in atherosclerosis and its therapeutic implications. Clin. Sci. (Lond). 107, 343–354 (2004).

    Bennett M. R. , 'Role of apoptosis in atherosclerosis and its therapeutic implications ' (2004 ) 107 Clin. Sci. (Lond) : 343 -354.

    • Search Google Scholar
  • Jang, J. Y., Jeon, Y. K., Choi, Y., Kim, C. W.: Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression. Mol. Cancer 9, 262 (2010).

    Kim C. W. , 'Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression ' (2010 ) 9 Mol. Cancer : 262 -.

    • Search Google Scholar
  • Shen, Y. H., Utama, B., Wang, J., Raveendran, M., Senthil, D., Waldman, W. J., Belcher, J. D., Vercellotti, G., Martin, D., Mitchelle, B. M., Wang, X. L.: Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways. Circ. Res. 94, 1310–1317 (2004).

    Wang X. L. , 'Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways ' (2004 ) 94 Circ. Res. : 1310 -1317.

    • Search Google Scholar
  • Reboredo, M., Greaves, R. F., Hahn, G.: Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication. J. Gen. Virol. 85, 3555–3567 (2004).

    Hahn G. , 'Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication ' (2004 ) 85 J. Gen. Virol. : 3555 -3567.

    • Search Google Scholar
  • Penfold, M. E., Dairaghi, D. J., Duke, G. M., Saederup, N., Mocarski, E. S., Kemble, G. W., Schall, T. J.: Cytomegalovirus encodes a potent alpha chemokine. Proc. Natl. Acad. Sci. US A 96, 9839–9844 (1999).

    Schall T. J. , 'Cytomegalovirus encodes a potent alpha chemokine ' (1999 ) 96 Proc. Natl. Acad. Sci. US A : 9839 -9844.

    • Search Google Scholar
  • Newby, A. C.: Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 85, 1–31 (2005).

    Newby A. C. , 'Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture ' (2005 ) 85 Physiol. Rev. : 1 -31.

    • Search Google Scholar
  • Román-García, P., Coto, E., Reguero, J. R., Cannata-Andía, J. B., Lozano, I., Avanzas, P., Morís, C., Rodríguez, I.: Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: A case-control study in a Spanish population. Coron. Artery Dis. 20, 383–386 (2009).

    Rodríguez I. , 'Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: A case-control study in a Spanish population ' (2009 ) 20 Coron. Artery Dis. : 383 -386.

    • Search Google Scholar
  • Clee, S. M.: A role for MMP-3 genetic variation in atherosclerosis susceptibility? Atherosclerosis 208, 30–31 (2010).

    Clee S. M. , 'A role for MMP-3 genetic variation in atherosclerosis susceptibility? ' (2010 ) 208 Atherosclerosis : 30 -31.

    • Search Google Scholar
  • Dargan, D. J., Jamieson, F. E., MacLean, J., Dolan, A., Addison, C., McGeoch, D. J.: The published DNA sequence of human cytomegalovirus strain AD169 lacks 929 base pairs affecting genes UL42 and UL43. J. Virol. 71, 9833–9836 (1997).

    McGeoch D. J. , 'The published DNA sequence of human cytomegalovirus strain AD169 lacks 929 base pairs affecting genes UL42 and UL43 ' (1997 ) 71 J. Virol. : 9833 -9836.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 8 0 0
May 2021 1 0 0
Jun 2021 2 0 0
Jul 2021 0 0 0
Aug 2021 19 0 0
Sep 2021 0 0 0
Oct 2021 0 0 0